Sunitinib Non Small Cell Lung Cancer Patients Over 70
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00864721. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II Trial of Sunitinib Malate in Previously Untreated NSCLC Patients Over the Age of 70
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this research study is to find out what effects (good and bad) sunitinib has on patients and their NSCLC.
Study identification
- NCT ID
- NCT00864721
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 63 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 70 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2009 (Type not available)
- Primary completion
- Jul 2012 (Actual)
- Completion
- Jul 2012 (Actual)
- Last update posted
- Oct 16, 2018
2009 – 2012
United States locations
- U.S. sites
- 13
- U.S. states
- 8
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ocala Oncology Center | Ocala | Florida | 34471 | — |
| Cancer Centers of Florida, P.A. | Ocoee | Florida | 34761 | — |
| Minnesota Oncology Hematology, P.A. | Minneapolis | Minnesota | 55404 | — |
| Cancer Centers of North Carolina | Raleigh | North Carolina | 27607 | — |
| Willamette Valley Cancer Institute and Research Center | Eugene | Oregon | 97401-8122 | — |
| Cancer Centers of the Carolinas | Greenville | South Carolina | 29605 | — |
| Texas Oncology - Arlington South | Arlington | Texas | 76014 | — |
| Texas Oncology, P.A. - Bedford | Bedford | Texas | 76022 | — |
| Methodist Charlton Cancer Ctr. | Dallas | Texas | 75237 | — |
| Texas Cancer Center of Mesquite | Mesquite | Texas | 75150 | — |
| Texas Oncology Cancer Care and Research Center | Waco | Texas | 76712 | — |
| Virginia Oncology Associates | Norfolk | Virginia | 23502 | — |
| Yakima Valley Mem Hosp/North Star Lodge | Yakima | Washington | 98902 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00864721, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 16, 2018 · Synced Nov 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.